Trial
NCT00103376
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Medical University of South Carolina
Collaborators
—
Condition
Prostate Cancer
Intervention
Velcade
Why stopped
Low Accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-05